297 related articles for article (PubMed ID: 33748697)
1. Common variants at 21q22.3 locus influence
Andolfo I; Russo R; Lasorsa VA; Cantalupo S; Rosato BE; Bonfiglio F; Frisso G; Abete P; Cassese GM; Servillo G; Esposito G; Gentile I; Piscopo C; Villani R; Fiorentino G; Cerino P; Buonerba C; Pierri B; Zollo M; Iolascon A; Capasso M
iScience; 2021 Apr; 24(4):102322. PubMed ID: 33748697
[TBL] [Abstract][Full Text] [Related]
2. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
Hou Y; Zhao J; Martin W; Kallianpur A; Chung MK; Jehi L; Sharifi N; Erzurum S; Eng C; Cheng F
BMC Med; 2020 Jul; 18(1):216. PubMed ID: 32664879
[TBL] [Abstract][Full Text] [Related]
3. Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses.
Rokni M; Heidari Nia M; Sarhadi M; Mirinejad S; Sargazi S; Moudi M; Saravani R; Rahdar S; Kargar M
Appl Biochem Biotechnol; 2022 Aug; 194(8):3507-3526. PubMed ID: 35386063
[TBL] [Abstract][Full Text] [Related]
4. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
Elhabyan A; Elyaacoub S; Sanad E; Abukhadra A; Elhabyan A; Dinu V
Virus Res; 2020 Nov; 289():198163. PubMed ID: 32918943
[TBL] [Abstract][Full Text] [Related]
5. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
Ma Y; Huang Y; Zhao S; Yao Y; Zhang Y; Qu J; Wu N; Su J
Hum Mol Genet; 2021 Jun; 30(13):1247-1258. PubMed ID: 33949668
[TBL] [Abstract][Full Text] [Related]
6. Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity.
Martinez-Diz S; Morales-Álvarez CM; Garcia-Iglesias Y; Guerrero-González JM; Romero-Cachinero C; González-Cabezuelo JM; Fernandez-Rosado FJ; Arenas-Rodríguez V; Lopez-Cintas R; Alvarez-Cubero MJ; Martinez-Gonzalez LJ
Hum Genomics; 2023 Jun; 17(1):50. PubMed ID: 37287057
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of IFN signaling genes and FOXP4 influence the severity of COVID-19.
Zhang F; Zhou P; Wang L; Liao X; Liu X; Ke C; Wen S; Shu Y
BMC Infect Dis; 2024 Mar; 24(1):270. PubMed ID: 38429664
[TBL] [Abstract][Full Text] [Related]
8.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Front Genet; 2021; 12():667231. PubMed ID: 33968142
[TBL] [Abstract][Full Text] [Related]
9. Assessment of risk conferred by coding and regulatory variations of
Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
J Genet; 2020; 99(1):. PubMed ID: 32661206
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
11. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
Rosendal E; Mihai IS; Becker M; Das D; Frängsmyr L; Persson BD; Rankin GD; Gröning R; Trygg J; Forsell M; Ankarklev J; Blomberg A; Henriksson J; Överby AK; Lenman A
mBio; 2022 Jun; 13(3):e0089222. PubMed ID: 35532162
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Infection Boosts
Bizzotto J; Sanchis P; Abbate M; Lage-Vickers S; Lavignolle R; Toro A; Olszevicki S; Sabater A; Cascardo F; Vazquez E; Cotignola J; Gueron G
iScience; 2020 Oct; 23(10):101585. PubMed ID: 32989429
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the clinical course of SARS-CoV-2 infections and ACE2 and TMPRSS2 expression and polymorphisms.
Tug E; Fidan I; Bozdayi G; Yildirim F; Tunccan OG; Lale Z; Akdogan D
Adv Clin Exp Med; 2024 Jan; 33(1):39-51. PubMed ID: 37326579
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population.
Yaghoobi A; Lord JS; Rezaiezadeh JS; Yekaninejad MS; Amini M; Izadi P
PLoS One; 2023; 18(2):e0281750. PubMed ID: 36795725
[TBL] [Abstract][Full Text] [Related]
15. Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis.
Smatti MK; Al-Sarraj YA; Albagha O; Yassine HM
Front Genet; 2020; 11():578523. PubMed ID: 33133166
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.
van der Made CI; Netea MG; van der Veerdonk FL; Hoischen A
Genome Med; 2022 Aug; 14(1):96. PubMed ID: 35986347
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
18. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
[TBL] [Abstract][Full Text] [Related]
20. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.
Fricke-Galindo I; Falfán-Valencia R
Front Immunol; 2021; 12():622176. PubMed ID: 33868239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
